One investor is counting on limited upside in Silver Standard
optionMONSTER's monitoring programs detected the sale of about
3,000 December 40 calls on the mining stock for $0.70 against open
interest of just 763 contracts. The trade obligates the investor to
sell SSRI for $14, but including the premium that translates into
He or she probably owns shares and is looking to
on their position. The move reflects a belief that upside in SSRI
will be limited over the next six sessions. If the stock closes
below $14 on expiration, they'll get to keep the shares and pocket
the premium. (See our
SSRI ended yesterday's session unchanged at $14.36 yesterday but
has lost more than half its value in the last three months.
More than 8,400 contracts traded in the name on Thursday's session,
about triple the daily average.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.
Copyright © 2010 OptionMonster® Holdings, Inc. All Rights Reserved.